FDA Referees Tablet Scoring Skirmish: Brand And Generic May Have Different Lines

FDA denied Warner Chilcott’s citizen petition requesting the agency not approve ANDAs referencing Doryx unless they were for dual-scored tablets; Mylan must make change from single-score in its second manufacturing run.